Information Technology [ 9/12 ] | Electronic Equipment, Instruments & Components [ 43/74 ]
NASDAQ | Common Stock
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally.
It operates in two segments, Automation Enabling Technologies and Medical Solutions.
The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles.
This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications.
The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; laser beam delivery solutions; video processing, streaming, and capture; machine vision technologies; radio frequency identification (RFID) technologies; barcode identification technologies; thermal chart recorders; light and color measurement technologies; touch panel displays; and advanced motion control solutions.
The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands.
The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016.
Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 26, 25 | 0.76 Increased by +20.63% | 0.71 Increased by +6.55% |
| Nov 5, 24 | 0.85 Increased by 0.00% | 0.85 |
| Aug 6, 24 | 0.73 Decreased by -8.75% | 0.69 Increased by +5.80% |
| May 7, 24 | 0.74 Increased by 0.00% | 0.58 Increased by +27.59% |
| Feb 28, 24 | 0.63 Decreased by -16.00% | 0.63 |
| Nov 7, 23 | 0.85 Increased by +4.94% | 0.74 Increased by +14.86% |
| Aug 8, 23 | 0.80 Increased by +2.56% | 0.73 Increased by +9.59% |
| May 9, 23 | 0.74 Increased by +1.37% | 0.64 Increased by +15.62% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 238.06 M Increased by +12.52% | 16.46 M Increased by +31.60% | Increased by +6.92% Increased by +16.95% |
| Sep 30, 24 | 244.41 M Increased by +10.34% | 19.19 M Decreased by -9.57% | Increased by +7.85% Decreased by -18.04% |
| Jun 30, 24 | 235.86 M Increased by +2.79% | 13.76 M Decreased by -34.12% | Increased by +5.83% Decreased by -35.91% |
| Mar 31, 24 | 230.92 M Increased by +5.38% | 14.68 M Decreased by -19.65% | Increased by +6.36% Decreased by -23.75% |
| Dec 31, 23 | 211.57 M Decreased by -3.12% | 12.51 M Decreased by -18.03% | Increased by +5.91% Decreased by -15.39% |
| Sep 30, 23 | 221.50 M Decreased by -0.65% | 21.22 M Decreased by -5.63% | Increased by +9.58% Decreased by -5.01% |
| Jun 30, 23 | 229.46 M Increased by +6.55% | 20.88 M Increased by +19.45% | Increased by +9.10% Increased by +12.11% |
| Mar 31, 23 | 219.13 M Increased by +7.30% | 18.27 M Decreased by -2.95% | Increased by +8.34% Decreased by -9.55% |